What about for the Generic industry, what trends are there in this sector?

  • More research activities for adapting existing products to the needs of developing countries.
  • Emerging examples of capacity advancement in the poor countries.
  • For the high-ranking generics companies, increased collaboration with originator companies through non-exclusive voluntary licensing arrangements
  • Low level of disclosure on the progress and outcome of access to medicine related initiatives